INVESTABOT
Equity Research
XNYS · PHARMACEUTICAL PREPARATIONS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Abbott Laboratories (ABT) had 1 Form 144 pre-sale notice filed on 2026-09-02. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Abbott Laboratories (ABT) had 1 Form 144 pre-sale notice filed on 2026-08-25. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Abbott Laboratories (ABT) had 1 Form 144 pre-sale notice filed on 2026-08-11. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
TL;DR: Abbott reported second-quarter 2026 revenue of $12.59B, up 13.0% from $11.14B a year ago, while raising its full-year adjusted EPS guidance range to $5.45–$5.60.
Abbott Laboratories (ABT) had 1 Form 144 pre-sale notice filed on 2026-05-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
open-market Form 4 only - grants, exercises, tax withholding excluded
0 buyers - 3 unique sellers · 9 accumulating - 5 trimming - 0 unchanged
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| September 23, 2026 | Conroy Kevin T | — | TAX_WITHHOLD | -52,507 | $104 | ~$5.5M |
| September 2, 2026 | Mccoy John A. Jr. | VICE PRESIDENT AND CONTROLLER | SELL | -27 | $110 | ~$3K |
| September 1, 2026 | Boudreau Philip P | EVP AND CFO | TAX_WITHHOLD | -388 | $110 | ~$43K |
| September 1, 2026 | Mccoy John A. Jr. | VICE PRESIDENT AND CONTROLLER | TAX_WITHHOLD | -52 | $110 | ~$6K |
| August 25, 2026 | Ford Robert B | CHAIRMAN AND CEO | OPTION_EXERCISE | 151,869 | $44 | ~$6.7M |
| August 25, 2026 | Ford Robert B | CHAIRMAN AND CEO | OPTION_EXERCISE | 246,963 | $60 | ~$14.8M |
| August 25, 2026 | Ford Robert B | CHAIRMAN AND CEO | SELL | -218,535 | $116 | ~$25.3M |
| August 25, 2026 | Ford Robert B | CHAIRMAN AND CEO | SELL | -180,297 | $116 | ~$20.9M |
| August 25, 2026 | Ford Robert B | CHAIRMAN AND CEO | OPTION_EXERCISE | -151,869 | — | — |
| August 25, 2026 | Ford Robert B | CHAIRMAN AND CEO | OPTION_EXERCISE | -246,963 | — | — |
| August 12, 2026 | Morrone Louis H. | EXECUTIVE VICE PRESIDENT | DISCRETIONARY | -12 | $108 | ~$1K |
| August 11, 2026 | Morrone Louis H. | EXECUTIVE VICE PRESIDENT | SELL | -5,850 | $110 | ~$0.6M |
| June 30, 2026 | Stratton John G | — | GRANT | 432 | $91 | ~$39K |
| June 30, 2026 | Roman Michael F | — | GRANT | 416 | $91 | ~$38K |
| June 30, 2026 | Gonzalez Patricia Paola | — | GRANT | 363 | $91 | ~$33K |
| June 30, 2026 | Conroy Kevin T | — | GRANT | 231 | $91 | ~$21K |
| June 30, 2026 | Ahuja Nita | — | GRANT | 347 | $91 | ~$31K |
| June 30, 2026 | Morrone Louis H. | EXECUTIVE VICE PRESIDENT | TAX_WITHHOLD | -269 | $93 | ~$25K |
| June 27, 2026 | Cushman Elizabeth C. | EVP, GC AND SECRETARY | TAX_WITHHOLD | -560 | $94 | ~$53K |
| May 7, 2026 | Stratton John G | — | BUY | 2,000 | $87 | ~$0.2M |
| Date | Insider | Title | Relationship | Shares | Filing |
|---|---|---|---|---|---|
| April 28, 2026 | — | — | — | — | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| BlackRock | 145,793,958 | ~$15.0B | 100.0% | May 13, 2026 |
| BlackRock | 152,563,476 | ~$13.8B | 4.6% | August 7, 2026 |
| State Street | 79,575,468 | ~$8.2B | 100.0% | May 15, 2026 |
| State Street | 80,926,234 | ~$7.3B | 1.7% | August 7, 2026 |
| Morgan Stanley | 30,101,596 | ~$3.1B | 100.0% | May 15, 2026 |
| JP Morgan Chase | 26,767,099 | ~$2.7B | 100.0% | May 13, 2026 |
| Morgan Stanley | 26,611,315 | ~$2.4B | -11.6% | August 13, 2026 |
| Goldman Sachs | 18,604,570 | ~$1.7B | 22.9% | August 14, 2026 |
| Goldman Sachs | 15,142,201 | ~$1.6B | 100.0% | May 15, 2026 |
| JP Morgan Chase | 15,113,798 | ~$1.4B | -43.5% | August 12, 2026 |
| Fidelity (FMR) | 13,423,080 | ~$1.2B | 23.8% | August 13, 2026 |
| Fidelity (FMR) | 10,845,315 | ~$1.1B | 100.0% | May 15, 2026 |
| Citadel Advisors | 12,066,927 | ~$1.1B | 215.9% | August 14, 2026 |
| Two Sigma | 8,221,115 | ~$746.0M | 27.6% | August 14, 2026 |
| Two Sigma | 6,441,328 | ~$661.3M | 100.0% | May 15, 2026 |
| DE Shaw | 5,397,254 | ~$554.1M | 100.0% | May 15, 2026 |
| Millennium Management | 4,405,494 | ~$399.8M | 133.5% | August 14, 2026 |
| Citadel Advisors | 3,820,246 | ~$392.2M | 100.0% | May 15, 2026 |
| AQR Capital | 4,193,058 | ~$380.5M | 166.6% | August 14, 2026 |
| Millennium Management | 1,886,942 | ~$193.7M | 100.0% | May 15, 2026 |